Lerimazoline (Trimazoline) hydrochloride is an α-adrenergic receptor agonist used as a nasal decongestant to inhibit mucus secretion. It serves as a research tool in pharmacological studies for investigating adrenergic signaling pathways in both in vitro and in vivo experimental models.